Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. GenFleet Therapeutics (Shanghai)'s Enterprise Value for Today is €896.17 Mil.
GenFleet Therapeutics (Shanghai) (HAM:Y3L) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
GenFleet Therapeutics (Shanghai) Market Cap Related Terms
GenFleet Therapeutics (Shanghai) Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GenFleet Therapeutics (Shanghai) Market Cap Chart
GenFleet Therapeutics (Shanghai) Annual Data
Trend
Dec23
Dec24
Dec25
Market Cap
0.00
0.00
0.00
GenFleet Therapeutics (Shanghai) Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
Market Cap
0.00
0.00
0.00
0.00
0.00
HAM:Y3L vs VRTX, REGN, RVMD: Market Cap Comparison
For the Biotechnology subindustry, GenFleet Therapeutics (Shanghai)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GenFleet Therapeutics (Shanghai) Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GenFleet Therapeutics (Shanghai)'s Market Cap distribution charts can be found below:
* The bar in red indicates where GenFleet Therapeutics (Shanghai)'s Market Cap falls into.
GenFleet Therapeutics (Shanghai) Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GenFleet Therapeutics (Shanghai) (HAM:Y3L) has a Market Cap of €1,149.41 Mil as of Aug. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on GenFleet Therapeutics (Shanghai) and its competitors. According to the industry distribution chart, GenFleet Therapeutics (Shanghai) ranks #230 out of 1423 companies in the Biotechnology industry, placing it in the top 16.2%.
Is GenFleet Therapeutics (Shanghai)'s Market Cap too high?
GenFleet Therapeutics (Shanghai)'s current Market Cap is €1,149.41 Mil. Based on the distribution chart, GenFleet Therapeutics (Shanghai) ranks #230 out of 1423 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, GenFleet Therapeutics (Shanghai) has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does GenFleet Therapeutics (Shanghai)'s Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GenFleet Therapeutics (Shanghai) ranks #230 out of 1423 companies for Market Cap. This places GenFleet Therapeutics (Shanghai) in the top 16% of its industry — outperforming the majority of peers. The industry median Market Cap is 114.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 114.69, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on GenFleet Therapeutics (Shanghai) and its competitors. For the Biotechnology industry, the median Market Cap is 114.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GenFleet Therapeutics (Shanghai)'s current Market Cap is €1,149.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GenFleet Therapeutics (Shanghai) stock overvalued right now?
GenFleet Therapeutics (Shanghai) (HAM:Y3L) has a current Market Cap of €1,149.41 Mil. The current Market Cap is €1,149.41 Mil. GenFleet Therapeutics (Shanghai)'s overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For GenFleet Therapeutics (Shanghai) (HAM:Y3L), the current Market Cap is €1,149.41 Mil as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GenFleet Therapeutics (Shanghai) Inc Company is a clinical-stage biotechnology company. The Company and its subsidiaries are principally engaged in the research, development and commercialisation of pharmaceutical products. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment.
19GF Score
Get the complete analysis for HAM:Y3L
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:Y3L has been successfully added to your 
